ANALYSIS OF YELLOW CARD REPORTING: ANNUAL REPORT FOR[removed]

First Page		Document Content
Date: 2014-04-24 13:04:45 Pharmaceutical sciences Drug safety Patient safety Pharmacy Piperazines Yellow Card Scheme Pharmacovigilance Adverse effect Adverse drug reaction Medicine Pharmacology Health		ANALYSIS OF YELLOW CARD REPORTING: ANNUAL REPORT FOR[removed] Add to Reading List Source URL: www.mhra.gov.uk Download Document from Source Website File Size: 1,37 MB Share Document on Facebook

	Managing patients’ safety: Need for PharmacoVigilance Dr. Hanmant Barkate, MBBS, MD Associate Vice-President& Head Medical, Clinical & Regulatory affairs Intas Pharmaceuticals Ltd., Ahmedabad DocID: 1rcEG - View Document
	Microsoft Word - Early access April 2014.docx DocID: 1pwXf - View Document
	Pharmacology–17 December Queen Elizabeth II Conference Centre London, UK UK medicines: regulatory science and innovation DocID: 1gvFH - View Document
	Microsoft Word - RBD web Sept _2_.doc DocID: 1g4WZ - View Document
	The Yellow Card Scheme: Reporting Medicine Side Effects If you are worried about a symptom you think may be a side effect…. 1. Check the leaflet supplied with the medicine DocID: 1bsVA - View Document